Teladoc Health (NYSE:TDOC) Given Hold Rating at Needham & Company LLC

Teladoc Health (NYSE:TDOC)‘s stock had its “hold” rating restated by analysts at Needham & Company LLC in a research report issued to clients and investors on Thursday, Benzinga reports.

A number of other brokerages also recently issued reports on TDOC. Canaccord Genuity Group dropped their price target on shares of Teladoc Health from $11.00 to $10.00 and set a “buy” rating on the stock in a report on Thursday, July 30th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Teladoc Health in a report on Wednesday, August 19th. Citigroup dropped their target price on Teladoc Health from $11.00 to $7.50 and set a “neutral” rating on the stock in a research report on Monday, August 3rd. Finally, Bank of America increased their price objective on shares of Teladoc Health from $9.00 to $10.50 and gave the stock a “buy” rating in a research note on Tuesday, July 7th. Five analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $7.54.

Teladoc Health Price Performance

TDOC opened at $6.87 on Thursday. Teladoc Health has a one year low of $4.40 and a one year high of $9.89. The firm has a market capitalization of $1.25 billion, a price-to-earnings ratio of -6.94 and a beta of 2.14. The business has a 50 day simple moving average of $6.15 and a two-hundred day simple moving average of $6.46.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Wednesday, October 28th. The health services provider reported ($0.15) EPS for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.07. The firm had revenue of $605.10 million for the quarter, compared to analysts’ expectations of $588.14 million. Teladoc Health had a negative net margin of 7.13% and a negative return on equity of 12.15%. The company’s quarterly revenue was down 3.4% on a year-over-year basis. During the same quarter in the previous year, the business posted ($0.28) EPS. As a group, sell-side analysts expect that Teladoc Health will post -0.92 EPS for the current fiscal year.

Insider Buying and Selling at Teladoc Health

In related news, CEO Charles III sold 17,805 shares of the stock in a transaction dated Friday, September 11th. The stock was sold at an average price of $6.10, for a total transaction of $108,610.50. Following the completion of the sale, the chief executive officer owned 465,535 shares in the company, valued at approximately $2,839,763.50. This trade represents a 3.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.70% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in shares of Teladoc Health during the 2nd quarter worth approximately $1,447,000. Monaco Asset Management SAM bought a new position in Teladoc Health during the second quarter valued at $26,864,000. ABS Investment Management LLC bought a new stake in shares of Teladoc Health in the 2nd quarter worth about $1,513,154. Counterpoint Mutual Funds LLC lifted its holdings in shares of Teladoc Health by 1,017.4% in the 3rd quarter. Counterpoint Mutual Funds LLC now owns 1,650,165 shares of the health services provider’s stock valued at $9,571,000 after acquiring an additional 1,502,488 shares during the last quarter. Finally, ABS Direct Equity Fund LLC purchased a new stake in Teladoc Health during the second quarter valued at approximately $1,513,000. 76.82% of the stock is currently owned by institutional investors.

Trending Headlines about Teladoc Health

Here are the key news stories impacting Teladoc Health this week:

• Positive Sentiment: Teladoc reported third-quarter revenue of $605.1 million, exceeding analyst expectations of approximately $588 million. Its adjusted loss of $0.15 per share was also narrower than the expected $0.23 loss, producing earnings and revenue surprises of roughly 35% and 3%, respectively. Teladoc Reports Q3 Loss, Beats Revenue Estimates
• Positive Sentiment: The results showed year-over-year improvement in the loss, with the quarterly loss per share improving from $0.21–$0.28 a year earlier to $0.15. BetterHelp insurance revenue reached $32 million, providing a potential growth avenue for the struggling mental-health business. Teladoc: 3 Key Takeaways for Long-Term Investors
• Positive Sentiment: From a technical perspective, TDOC shares crossed above their 200-day moving average, a development that can attract momentum-oriented investors and signal improving market sentiment after a prolonged decline. Teladoc Shares Cross Above 200-Day Moving Average
• Neutral Sentiment: Management forecast fourth-quarter revenue of $569 million to $615 million, or approximately $592 million at the midpoint. The range provides visibility into the near-term outlook, although the midpoint is slightly below consensus expectations. Teladoc Expects Q4 Revenue Range
• Negative Sentiment: Third-quarter revenue declined 3.4% year over year, showing that Teladoc remains in a low-growth environment despite beating estimates. The company also continued to report a net loss and negative profitability metrics. Teladoc Third-Quarter Earnings Results
• Negative Sentiment: The fourth-quarter revenue outlook remains subdued, reinforcing concerns that BetterHelp and the broader virtual-care business may need more time to return to sustained growth. Teladoc Q3 2026 Earnings Call Transcript

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services and technology designed to connect patients with medical professionals remotely. Through its digital platforms, the company supports a range of healthcare needs, including general medical consultations, mental health services, specialty care, and ongoing management of chronic conditions.

Its offerings include telehealth visits with physicians and other licensed providers, behavioral health services through BetterHelp, and chronic care programs that use digital tools and clinical support to help people manage conditions such as diabetes and hypertension.